Newron Pharmaceuticals SpA had a revenue of 3.41M in the quarter ending Jun 30, 2024, with -4.38%. This bring the company's revenue in the last twelve months to 6.97M, Increased -23.04%. In the fiscal year ending Dec 31, 2023, Newron Pharmaceuticals SpA had annual revenue of 9.06M with 48.62% growth.